# ‘Slow as molasses:’ Cannabis cultivators decry licensing delays in Rhode Island > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/rhode-island-cannabis-licensing-delays-impact-patient-access/ > **Published:** 2026-04-14T14:03:56-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:09-04:00 > **Clinical Summary:** Rhode Island cannabis licensing delays frustrate cultivators and applicants, impacting patient access to regulated cannabis products and safety standards. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic RegulationPatient AccessQuality Control[State Policy](https://cedclinic.com/will-the-coronavirus-force-states-to-legalize-marijuana/)Product Safety Why This Matters Licensing delays and regulatory bottlenecks directly impact patient access to quality-controlled cannabis products. When regulatory processes stall, patients may turn to unregulated sources with unknown safety profiles and inconsistent dosing. Clinical Summary Rhode Island cannabis cultivators and license applicants are experiencing significant delays in the state’s licensing process, with stakeholders describing the pace as frustratingly slow. This regulatory gridlock affects the establishment of legal cannabis businesses and potentially limits patient access to regulated products. Such delays are common during early implementation phases of state cannabis programs, often reflecting administrative capacity constraints and regulatory complexity. Dr. Caplan’s Take “Regulatory delays aren’t just bureaucratic inconveniences—they’re patient access issues. When legal pathways are blocked or delayed, patients don’t stop needing [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/); they just find it elsewhere, often without the safety oversight that proper regulation provides.” Clinical Perspective 🧠 Clinicians should be aware that regulatory delays may drive patients toward unregulated sources with variable product quality and potency. Consider discussing sourcing strategies with patients and emphasizing the importance of consistent, tested products when making dosing recommendations. Monitor for changes in patient response that might reflect product variability. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20%27Slow%20as%20molasses%3A%27%20Cannabis%20cultivators%2C%20applicants%2C%20decry%20licensing%20-%20The%20Prov...%20%40drcaplan&url=https%3A//www.providencejournal.com/videos/news/state/2026/04/14/rhode-island-cannabis-cultivators-applicants-decry-licensing-canabis-control-commission/89598889007/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.providencejournal.com/videos/news/state/2026/04/14/rhode-island-cannabis-cultivators-applicants-decry-licensing-canabis-control-commission/89598889007/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20%27Slow%20as%20molasses%3A%27%20Cannabis%20cultivators%2C%20applicants%2C%20decry%20licensing%20-%20The%20Prov...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.providencejournal.com/videos/news/state/2026/04/14/rhode-island-cannabis-cultivators-applicants-decry-licensing-canabis-control-commission/89598889007/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.providencejournal.com/videos/news/state/2026/04/14/rhode-island-cannabis-cultivators-applicants-decry-licensing-canabis-control-commission/89598889007/](https://www.providencejournal.com/videos/news/state/2026/04/14/rhode-island-cannabis-cultivators-applicants-decry-licensing-canabis-control-commission/89598889007/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What type of cannabis-related topics does this news cover?](#What_type_of_cannabis-related_topics_does_this_news_cover) - [Why is this news marked as “New”?](#Why_is_this_news_marked_as_8220New8221) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How does this relate to the CED Clinic’s mission?](#How_does_this_relate_to_the_CED_Clinic8217s_mission) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating signifies emerging findings or policy developments that warrant close monitoring by healthcare professionals. #### What type of cannabis-related topics does this news cover? The article covers multiple important areas including regulation, patient access, quality control, and [state policy](https://cedclinic.com/will-the-coronavirus-force-states-to-legalize-marijuana/). These topics are particularly relevant for clinicians working with [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients. #### Why is this news marked as “New”? The “New” designation indicates this is recently published information that may impact clinical practice. Healthcare providers should stay current with these developments to provide the best [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). #### What does “Notable Clinical Interest” mean for healthcare providers? This classification suggests the information contains emerging findings or policy changes that could influence clinical decision-making. Providers should monitor these developments as they may affect treatment protocols or patient access to [cannabis therapies](https://cedclinic.com/deep-reading-decline-digital-age-insights/). #### How does this relate to the CED Clinic’s mission? The CED Clinic focuses on providing evidence-based information about [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). This news article contributes to their goal of keeping healthcare professionals informed about important regulatory and clinical developments in the field. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Retail cannabis applicants vent after ruling stalls an already 'slow as molasses' license rollout](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) Explore how recent rulings have further delayed cannabis license rollouts, frustrating retail applicants. [Read More](https://cedclinic.com/cannabis-retail-licensing-delays-stall-patient-access/) [Virginia cannabis business registration moves forward | Local | mesabitribune.com](https://cedclinic.com/virginia-adult-use-cannabis-registration-advances-2026/) Learn about progress in cannabis business registration in Virginia amidst regulatory challenges. [Learn More](https://cedclinic.com/virginia-adult-use-cannabis-registration-advances-2026/) [Why Every State Needs a Cannabis Ombudsman](https://cedclinic.com/why-every-state-needs-a-cannabis-ombudsman/) Discover the role of a cannabis ombudsman in addressing licensing delays and improving regulatory processes. [Discover More](https://cedclinic.com/why-every-state-needs-a-cannabis-ombudsman/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).